DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Jacot W, Cottu P, Berger F. et al.
Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial.
Breast Cancer Res 2019;
21: 121
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.